Stay updated with breaking news from Precision Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Palantir Technologies (PLTR) shares dip premarket despite multi-year partnership with Parexel to enhance clinical trials efficiency using AI platforms.
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more...
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more...